在全科医生 (GP) 实践中缩小吸烟者和高风险酒精使用者的骨质疏松风险评估差距
Basak Selin Kara1, Nidhi Sehgal2
1General Practice, Health Education East of England, Cambridge, GBR.
Cureus
|December 1, 2025
概括
这项质量改进项目成功提高了高风险患者的骨质疏松风险评估,使用系统的电子健康记录搜索和多学科团队参与. 该倡议显著改善了骨折风险评估工具 (FRAX) 文档和初级保健中双能X射线吸收计 (DXA) 扫描率.
科学领域:
- 主要护理医学 医疗保健
- 提高医疗保健的质量 改善医疗保健的质量
- 骨健康和骨质疏松症管理
背景情况:
- 骨质疏松症具有显著的骨折风险,特别是在具有可修改的生活方式因素的老年人中.
- 在初级保健机构中,在高风险群体中识别和管理骨质疏松症风险需要系统的方法.
- 50岁以上的吸烟者和高风险的酒精消费者是针对骨质疏松症查的关键人口.
研究的目的:
- 改善50岁以上吸烟和过度饮酒的患者骨质疏松症风险的识别,管理和记录.
- 使用计划-执行-研究-行为 (PDSA) 框架实施和评估质量改进项目.
- 在这个高风险队列中增加骨折风险评估工具 (FRAX) 评分和双能X射线吸收计 (DXA) 扫描率.
主要方法:
- 在一般实践中进行了一项为期三个周期的PDSA质量改进项目.
- 符合条件的患者通过系统的电子健康记录 (SystmOne) 搜索来确定.
- 干预措施包括FRAX评分,患者外展,药剂师参与和电子提示在EHR系统内.
主要成果:
- FRAX文档从基线时的2.05%增加到干预后的100% (p<0.001).
- 需要评估的患者的DXA扫描率从9.09%上升到50% (p=0.0068).
- 在DXA扫描的患者中,诊断包括骨质疏松症 (22.2%),骨质疏松症 (55.6%) 和正常的骨密度 (22.2%).
结论:
- 系统的质量改善干预措施显著提高骨质疏松症风险评估和管理在初级保健.
- 电子健康记录整合和多学科团队合作是改善骨健康结果的有效策略.
- 有针对性的QI举措可以大大改善脆弱性骨折风险评估和高风险人群的预防措施.
关键词:
dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa dxa脆弱性骨折的骨折是一种脆弱性骨折.在Frax Frax中使用.骨质疏松症是一种骨质疏松症.首要预防 首要预防相关概念视频
Stress Prevention and Stress Management Techniques IV
214
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
214
Atherosclerosis III: Management
296
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Coronary Artery Disease IV: Preventive Measures
575
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
575
Acute Coronary Syndrome IV: Interprofessional Care
200
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
200
Peripheral Artery Disease III: Interprofessional Care
226
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K

